Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2) — Stella
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(159 sites) United States
GSK Investigational Site, Sheffield, Alabama GSK Investigational Site, Aurora, Colorado GSK Investigational Site, Brooksville, Florida GSK Investigational Site, Doral, Florida GSK Investigational Site, Fort Lauderdale, Florida GSK Investigational Site, Miami, Florida GSK Investigational Site, Miami, Florida GSK Investigational Site, Miami, Florida GSK Investigational Site, Miami, Florida GSK Investigational Site, Miami, Florida GSK Investigational Site, Miami, Florida GSK Investigational Site, Miami, Florida GSK Investigational Site, Miami Lakes, Florida GSK Investigational Site, Naples, Florida GSK Investigational Site, New Port Richey, Florida GSK Investigational Site, Ocala, Florida GSK Investigational Site, Orlando, Florida GSK Investigational Site, Ormond Beach, Florida GSK Investigational Site, Palmetto Bay, Florida GSK Investigational Site, St. Petersburg, Florida GSK Investigational Site, Adairsville, Georgia GSK Investigational Site, Cordele, Georgia GSK Investigational Site, East Point, Georgia GSK Investigational Site, Morrow, Georgia GSK Investigational Site, Boise, Idaho GSK Investigational Site, Chicago, Illinois GSK Investigational Site, Baton Rouge, Louisiana GSK Investigational Site, Lafayette, Louisiana GSK Investigational Site, Shreveport, Louisiana GSK Investigational Site, Bangor, Maine GSK Investigational Site, Rockville, Maryland GSK Investigational Site, Allen Park, Michigan GSK Investigational Site, Detroit, Michigan GSK Investigational Site, Garden City, Michigan GSK Investigational Site, Troy, Michigan GSK Investigational Site, Las Vegas, Nevada GSK Investigational Site, Moorestown, New Jersey GSK Investigational Site, Sewell, New Jersey GSK Investigational Site, Mount Kisco, New York GSK Investigational Site, New Windsor, New York GSK Investigational Site, Shelby, North Carolina GSK Investigational Site, DuBois, Pennsylvania GSK Investigational Site, Philadelphia, Pennsylvania GSK Investigational Site, Spartanburg, South Carolina GSK Investigational Site, Union, South Carolina GSK Investigational Site, Knoxville, Tennessee GSK Investigational Site, Austin, Texas GSK Investigational Site, Dallas, Texas GSK Investigational Site, El Paso, Texas GSK Investigational Site, Houston, Texas GSK Investigational Site, Lampasas, Texas GSK Investigational Site, Richmond, Texas GSK Investigational Site, San Antonio, Texas GSK Investigational Site, Webster, Texas GSK Investigational Site, Morgantown, West Virginia Argentina
GSK Investigational Site, Buenos Aires GSK Investigational Site, Buenos Aires GSK Investigational Site, Córdoba GSK Investigational Site, Quilmes GSK Investigational Site, Santa Fe Australia
GSK Investigational Site, Coffs Harbour, New South Wales GSK Investigational Site, Maroubra, New South Wales GSK Investigational Site, Westmead, New South Wales GSK Investigational Site, Midland, Western Australia Austria
GSK Investigational Site, Graz GSK Investigational Site, Innsbruck GSK Investigational Site, Klagenfurt GSK Investigational Site, Linz GSK Investigational Site, Linz GSK Investigational Site, Linz GSK Investigational Site, Vienna Bulgaria
GSK Investigational Site, Dupnitsa GSK Investigational Site, Haskovo GSK Investigational Site, Lovech GSK Investigational Site, Montana GSK Investigational Site, Montana GSK Investigational Site, Pleven GSK Investigational Site, Rousse GSK Investigational Site, Rousse GSK Investigational Site, Sofia GSK Investigational Site, Sofia Czechia
GSK Investigational Site, Jindřichův Hradec GSK Investigational Site, Kralupy nad Vltavou GSK Investigational Site, Nymburk GSK Investigational Site, Prague GSK Investigational Site, Varnsdorf Germany
GSK Investigational Site, Munich, Bavaria GSK Investigational Site, Offenbach, Hesse GSK Investigational Site, Rheine, North Rhine-Westphalia GSK Investigational Site, Bendorf GSK Investigational Site, Berlin GSK Investigational Site, Berlin GSK Investigational Site, Berlin GSK Investigational Site, Berlin GSK Investigational Site, Berlin GSK Investigational Site, Berlin GSK Investigational Site, Berlin GSK Investigational Site, Darmstadt GSK Investigational Site, Essen GSK Investigational Site, Fürstenwalde
Greece
GSK Investigational Site, Exochi, Thessaloniki GSK Investigational Site, Alexandroupoli GSK Investigational Site, Athens GSK Investigational Site, Ioannina GSK Investigational Site, Marousi Israel
GSK Investigational Site, Ashkelon GSK Investigational Site, Beer-Yaakov GSK Investigational Site, Beersheba GSK Investigational Site, Haifa GSK Investigational Site, Haifa GSK Investigational Site, Haifa GSK Investigational Site, Jerusalem GSK Investigational Site, Jerusalem GSK Investigational Site, Kfar Saba GSK Investigational Site, Petah Tikva GSK Investigational Site, Ramat Gan Italy
GSK Investigational Site, Catania GSK Investigational Site, Ferrara GSK Investigational Site, Foggia GSK Investigational Site, Genova GSK Investigational Site, Roma GSK Investigational Site, Roma GSK Investigational Site, Roma GSK Investigational Site, Telese Terme Latvia
GSK Investigational Site, Daugavpils GSK Investigational Site, Riga GSK Investigational Site, Riga New Zealand
GSK Investigational Site, Takapuna, Auckland GSK Investigational Site, Auckland GSK Investigational Site, Auckland GSK Investigational Site, Christchurch GSK Investigational Site, Ebdentown GSK Investigational Site, Hamilton GSK Investigational Site, Rotorua Romania
GSK Investigational Site, Oradea, Bihor County GSK Investigational Site, Oradea, Bihor County GSK Investigational Site, Timișoara, Timiș County GSK Investigational Site, Bucharest GSK Investigational Site, Cluj-Napoca GSK Investigational Site, Cluj-Napoca GSK Investigational Site, Constanța South Korea
GSK Investigational Site, Seoul GSK Investigational Site, Seoul United Kingdom
GSK Investigational Site, Corby GSK Investigational Site, Dagenham GSK Investigational Site, Glasgow GSK Investigational Site, Glasgow GSK Investigational Site, London GSK Investigational Site, London GSK Investigational Site, Uxbridge Key details Enrollment target
~960 participants
Primary completion
August 2029
Age range
40 Years – 80 Years
Last updated April 2026
Interested in joining? GSK Investigational Site, Geesthacht
GSK Investigational Site, Giessen GSK Investigational Site, Halle GSK Investigational Site, Immenhausen GSK Investigational Site, Leipzig GSK Investigational Site, Leipzig GSK Investigational Site, Leipzig GSK Investigational Site, Lübeck GSK Investigational Site, Schleswig